COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1698: Articles 16971-16980  | Next

Day Camp in the Time of COVID-19: What Went Right?
Nachman, S., Brauner, G., Beleck, A., Handel, A. S.
10.1101/2021.03.11.21253309 — Posted: 2021-03-12
Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries
Linschoten, M., Asselbergs, F. W., CAPACITY-COVID collaborative consortium, , LEOSS Study Group
10.1101/2021.03.11.21253106 — Posted: 2021-03-12
An international comparison of age and sex dependency of COVID-19 Deaths in 2020 - a descriptive analysis
Bauer, P., Brugger, J., Koenig, F., Posch, M.
10.1101/2021.03.11.21253420 — Posted: 2021-03-12
Pre-existing health conditions and severe COVID-19 infection: Analysis of commercial health insurance data from 690,000 infected patients
Wineinger, N. E., Li, V., Waalen, J., Topol, E. J.
10.1101/2021.03.11.21252708 — Posted: 2021-03-12
A novel whole-blood stimulation assay to detect and quantify memory T-cells in COVID-19 patients
Mouton, W., Compagnon, C., Saker, K., Daniel, S., Lacoux, X., Pozzetto, B., Oriol, G., Djebali, S., Berthier, F., Marvel, J., Walzer, T., Brengel-Pesce, K., Trouillet-Assant, S., COVID-ser study group
10.1101/2021.03.11.21253202 — Posted: 2021-03-12
Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise ship
Kaku, N., Nishimura, F., Shigeishi, Y., Tachiki, R., Sakai, H., Sasaki, D., Ota, K., Sakamoto, K., Kosai, K., Hasegawa, H., Izumikawa, K., Ariyoshi, K., Mukae, H., Yasuda, J., Morita, K., Konno, S., Yanagihara, K.
10.1101/2021.03.10.21253064 — Posted: 2021-03-12
Characterizing the COVID-19 illness experience to inform the study of post-acute sequalae and recovery: a qualitative study
Santiago-Rodriguez, E. I., Maiorana, A., Peluso, M. J., Hoh, R., Tai, V., Fehrman, E. A., Hernandez, Y., Torres, L., Spinelli, M. A., Gandhi, M., Kelly, J. D., Martin, J. N., Henrich, T. J., Deeks, S. G., Sauceda, J. A.
10.1101/2021.03.10.21253330 — Posted: 2021-03-12
Evolution of antibodies against SARS-CoV-2 over seven months: experience of the Nationwide Seroprevalence ENE-COVID Study in Spain
Perez-Olmeda, M., Saugar, J. M., Fernandez-Garcia, A., Perez-Gomez, B., Pollan, M., Avellon, A., Pastor-Barriuso, R., Fernandez-de Larrea, N., Martin, M., Cruz, I., Sanmartin, J. L., Fedele, G., Paniagua, J. L., Munoz-Montalvo, J. F., Blanco, F., Yotti, R., Oteo-Iglesias, J., ENE-COVID Study Group
10.1101/2021.03.11.21253142 — Posted: 2021-03-12
Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination
Rottenstreich, A., Zarbiv, G., Oiknine-Djian, E., Zigron, R., Wolf, D. G., Porat, S.
10.1101/2021.03.11.21253352 — Posted: 2021-03-12
Optimal vaccination strategies for COVID-19 based on dynamical social networks with real-time updating
Cheng, S., Arcucci, R., Pain, C., Guo, Y.
10.1101/2021.03.11.21253356 — Posted: 2021-03-12 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).